Cleared Traditional

K882696 - DERMICEL, MONTGOMERY STRAP

K882696 is an FDA 510(k) clearance for DERMICEL, manufactured by Bioseal. The device is a Class 1 General & Plastic Surgery device with product code NAD cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K882696 · Bioseal · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
60d
Days
Class 1
Risk

K882696 is an FDA 510(k) clearance for the DERMICEL, MONTGOMERY STRAP. Classified as Dressing, Wound, Occlusive (product code NAD), Class I - General Controls.

Submitted by Bioseal (Brea, US). The FDA issued a Cleared decision on August 26, 1988 after a review of 60 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4020 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bioseal devices

FDA 510(k) Submission Details - K882696

510(k) Number K882696 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 1988
Decision Date August 26, 1988
Days to Decision 60 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 115d · This submission: 60d
Pathway characteristics
Predicate-based equivalence.

NAD Device Classification - Class 1, General Controls

Product Code NAD Dressing, Wound, Occlusive
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4020
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - NAD Dressing, Wound, Occlusive

All 56
Devices cleared under the same product code (NAD) and FDA review panel - the closest regulatory comparables to K882696.
POLYMER ADHESIVE BANDAGE
K883391 · Marion Laboratories, Inc. · Mar 1989
ALLEVYN TRACHEOSTOMY DRESSING
K890748 · Smith & Nephew United, Inc. · Mar 1989
TECNOL VARIABLE TENSION BANDAGE
K884440 · Tecnol New Jersey Wound Care, Inc. · Jan 1989
3M WOUND CONTACT MATERIAL, PRODUCT #563X
K881988 · 3M Company · Jun 1988
DUODERM(R) CGF
K881050 · Convatec, A Division of E.R. Squibb & Sons · Apr 1988
ENVICLUSIVE (TM)
K874554 · Marion Laboratories, Inc. · Mar 1988